Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
April 25, 2025
Fred Hutch PhD student honored by American Society of Hematology
Rasika Venkataraman awarded ASH Graduate Hematology Award for research on DDX41 mutations
From predicted neoantigen to T cell therapy for acute myeloid leukemia
From the Bleakley Lab, Cancer Consortium and Translational Science & Therapeutics Division
Holland receives NCI Outstanding Investigator Award
Neuroscientist will tackle genetic abnormalities that drive cancers and could be therapeutic targets
New research uncovers how common genetic mutation drives cancer
Findings in Nature show that targeted therapy for mutated gene can slow or prevent tumor growth in many kinds of cancer
Good News: Dr. Jeff Whiteaker wins NCI Research Specialist Award; Human Biology gains four new faculty members
Celebrating faculty and staff achievements
Inherited mutations tied to advanced prostate cancer
Genetic screening could help men with prostate cancer find better treatments — and alert family members to their own cancer risk
Study sheds new light on molecular pathways behind marrow disorders
How a single alteration in fundamental cellular machinery drives blood diseases and cancers
Seattle researchers map genome of advanced, lethal prostate cancers and discover 'hypermutations'
First comprehensive assessment of DNA errors that drive advanced prostate cancer
Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy
Mechanism of cisplatin resistance 'unlike any previously identified'
New study provides a clearer picture of breast-cancer gene mutations in American women
Findings shed new light on mutation risk in older and African-American women